To test how 5-aza-2???-deoxycytidine (5-aza-CdR) influences the genome therapeutically, we exposed non-malignant cells in culture to the agent and used genome-wide assays to assess the cellular response. Results We found that cells allowed to recover from 5-aza-CdR treatment only partially...